Arno Amann
Innsbruck, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
AGMT mCRC Registry Third-Line and Beyond: a multicentric real-world platform with integrated imaging and biosample database for later-line metastatic colorectal cancer.
Journal: Future oncology (London, England)
Published: March 20, 2026
Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report.
Journal: JTO clinical and research reports
Published: September 12, 2025
Erratum: [Corrigendum] The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines.
Journal: Oncology letters
Published: July 04, 2025
Ex vivo modelling of human colorectal cancer liver metastasis by normothermic machine perfusion.
Journal: Molecular cancer
Published: June 04, 2025
Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancer.
Journal: Cancer cell
Published: February 25, 2025
Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE.
Journal: International journal of cancer
Published: January 28, 2025
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies.
Journal: NPJ precision oncology
Published: December 05, 2024
Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?
Journal: Current oncology reports
Published: July 11, 2024
Prognostic and functional role of the nuclear export receptor 1 (XPO1) in gastrointestinal cancers: a potential novel target?
Journal: Molecular biology reports
Published: June 18, 2024
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC.
Journal: Oncoimmunology
Published: December 21, 2023
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases-a phase II study.
Journal: Frontiers in oncology
Published: May 30, 2023
Last Updated: 09/26/2026